forty-four patients with progressive symptomatic multiple myeloma were treated with a protocol combining cyclophosphamide ( 10 mg/kg weekly ) , procarbazine ( 2 mg/kg daily ) , prednisolone ( 20 mg daily ) , and either bcnu ( 1 mg/kg weekly ) ( bcpp protocol ) or mcnu ( 0.8-1 mg/kg ) ( mcpp protocol ) .
C0026764
multiple myeloma
C0010583
cyclophosphamide